IN THIS ISSUE
Legislation & Regulation: Campaign 2016
Richard Mark Kirkner
Adverse selection, other problems may hinder the presumptive Democratic candidate’s proposal to let people buy into Medicare in their 50s.
Value-Based Care
Michael D. Dalzell
CMS’s data-liberation movement is helping to accelerate the transition to value- and risk-based payment systems. For payers and providers, the trick is knowing what to do with the data.
Tomorrow’s Medicine
Thomas Morrow, MD

Thomas Morrow, MD

Studies show Eli Lilly’s Taltz achieves higher remission rates than its main competitor but is also marked by slightly more infections.
Viewpoint
Saskia Siderow
Allison Silvers, MBA
Diane E. Meier, MD
Care targeting pain and symptoms has caught the eye of insurers.
News & Commentary

Marilyn Tavenner
AHIP